Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

With the widespread use of ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI), there has been an increase in the detection of various subtypes of renal cell carcinomas (RCCs) and benign renal tumors. The differentiation of RCCs from benign tumors such as fat-poor angiomyolipoma and oncocytoma is very important to prevent unnecessary surgery. In addition, the recent progress of therapies to treat RCCs, including nephronsparing surgery, percutaneous ablative procedures, and targeted antiangiogenic therapies, has increased the need for the accurate determination of subtypes and staging. With the development of imaging modalities, there have been significant improvements in correlating preoperative imaging with pathologic characteristics. Many studies performed within the last two decades have helped to clarify diagnostic imaging clues for both cystic and solid renal tumors. In this chapter, we discuss the current status of US, CT, and MRI for the detection and differential diagnosis of renal tumors as well as staging, postprocedural imaging, and imaging for the targeted antiangiogenic treatment of RCC.

Original languageEnglish
Title of host publicationRenal Cell Carcinoma
Subtitle of host publicationMolecular Features and Treatment Updates
PublisherSpringer Japan
Pages139-176
Number of pages38
ISBN (Electronic)9784431555315
ISBN (Print)9784431555308
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Renal Cell Carcinoma
Differential Diagnosis
Cells
Imaging techniques
Kidney
Tumors
Ultrasonography
Neoplasms
Tomography
Magnetic Resonance Imaging
Oxyphilic Adenoma
Unnecessary Procedures
Angiomyolipoma
Magnetic resonance
Surgery
Diagnostic Imaging
Fats
Therapeutics

Keywords

  • Cystic renal tumor
  • Differential diagnosis
  • Solid renal tumor
  • Staging

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation. / Jinzaki, Masahiro; Akita, Hirotaka; Oya, Mototsugu.

Renal Cell Carcinoma: Molecular Features and Treatment Updates. Springer Japan, 2017. p. 139-176.

Research output: Chapter in Book/Report/Conference proceedingChapter

Jinzaki, Masahiro ; Akita, Hirotaka ; Oya, Mototsugu. / Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation. Renal Cell Carcinoma: Molecular Features and Treatment Updates. Springer Japan, 2017. pp. 139-176
@inbook{9c660055315844a28c5e6bb91c060e04,
title = "Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation",
abstract = "With the widespread use of ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI), there has been an increase in the detection of various subtypes of renal cell carcinomas (RCCs) and benign renal tumors. The differentiation of RCCs from benign tumors such as fat-poor angiomyolipoma and oncocytoma is very important to prevent unnecessary surgery. In addition, the recent progress of therapies to treat RCCs, including nephronsparing surgery, percutaneous ablative procedures, and targeted antiangiogenic therapies, has increased the need for the accurate determination of subtypes and staging. With the development of imaging modalities, there have been significant improvements in correlating preoperative imaging with pathologic characteristics. Many studies performed within the last two decades have helped to clarify diagnostic imaging clues for both cystic and solid renal tumors. In this chapter, we discuss the current status of US, CT, and MRI for the detection and differential diagnosis of renal tumors as well as staging, postprocedural imaging, and imaging for the targeted antiangiogenic treatment of RCC.",
keywords = "Cystic renal tumor, Differential diagnosis, Solid renal tumor, Staging",
author = "Masahiro Jinzaki and Hirotaka Akita and Mototsugu Oya",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-4-431-55531-5_5",
language = "English",
isbn = "9784431555308",
pages = "139--176",
booktitle = "Renal Cell Carcinoma",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Imaging features of renal cell carcinoma differential diagnosis, staging, and posttreatment evaluation

AU - Jinzaki, Masahiro

AU - Akita, Hirotaka

AU - Oya, Mototsugu

PY - 2017/1/1

Y1 - 2017/1/1

N2 - With the widespread use of ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI), there has been an increase in the detection of various subtypes of renal cell carcinomas (RCCs) and benign renal tumors. The differentiation of RCCs from benign tumors such as fat-poor angiomyolipoma and oncocytoma is very important to prevent unnecessary surgery. In addition, the recent progress of therapies to treat RCCs, including nephronsparing surgery, percutaneous ablative procedures, and targeted antiangiogenic therapies, has increased the need for the accurate determination of subtypes and staging. With the development of imaging modalities, there have been significant improvements in correlating preoperative imaging with pathologic characteristics. Many studies performed within the last two decades have helped to clarify diagnostic imaging clues for both cystic and solid renal tumors. In this chapter, we discuss the current status of US, CT, and MRI for the detection and differential diagnosis of renal tumors as well as staging, postprocedural imaging, and imaging for the targeted antiangiogenic treatment of RCC.

AB - With the widespread use of ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI), there has been an increase in the detection of various subtypes of renal cell carcinomas (RCCs) and benign renal tumors. The differentiation of RCCs from benign tumors such as fat-poor angiomyolipoma and oncocytoma is very important to prevent unnecessary surgery. In addition, the recent progress of therapies to treat RCCs, including nephronsparing surgery, percutaneous ablative procedures, and targeted antiangiogenic therapies, has increased the need for the accurate determination of subtypes and staging. With the development of imaging modalities, there have been significant improvements in correlating preoperative imaging with pathologic characteristics. Many studies performed within the last two decades have helped to clarify diagnostic imaging clues for both cystic and solid renal tumors. In this chapter, we discuss the current status of US, CT, and MRI for the detection and differential diagnosis of renal tumors as well as staging, postprocedural imaging, and imaging for the targeted antiangiogenic treatment of RCC.

KW - Cystic renal tumor

KW - Differential diagnosis

KW - Solid renal tumor

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85019484267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019484267&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-55531-5_5

DO - 10.1007/978-4-431-55531-5_5

M3 - Chapter

SN - 9784431555308

SP - 139

EP - 176

BT - Renal Cell Carcinoma

PB - Springer Japan

ER -